Study
Comprehensive Genomic and Transcriptomic Analysis of Rare Cancers for Guiding of Therapy (H021)
Study ID | Alternative Stable ID | Type |
---|---|---|
EGAS00001004813 | Other |
Study Description
Here we analyzed the molecular profiles and clinical outcomes of 1,310 patients (proportion of rare cancers, 75%) enrolled in a prospective observational study by the German Cancer Consortium that applies whole-genome/exome and RNA sequencing to inform the care of adults with incurable cancers. Based on 472 single and six composite biomarkers, a cross-institutional molecular tumor board provided evidence-based management recommendations, including diagnostic reevaluation, genetic counseling, and experimental treatment, in 88% of cases. Recommended therapies were administered in 362 of 1,138 patients (31.8%) and resulted in significantly improved response and disease control rates (23.9% and 55.3%, respectively) compared to previous therapies, translating into a progression-free survival ratio >1.3 in 35.7% of patients.
Study Datasets 67 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001008844 |
Rare cancer sequencing data of 23 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 16 |
EGAD00001008845 |
Rare cancer sequencing data of 28 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 22 |
EGAD00001008846 |
Rare cancer sequencing data of 45 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 26 |
EGAD00001008847 |
Rare cancer sequencing data of 95 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 64 |
EGAD00001008848 |
Rare cancer sequencing data of 55 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 44 |
EGAD00001008849 |
Rare cancer sequencing data of 87 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 58 |
EGAD00001008850 |
Rare cancer sequencing data of 59 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 38 |
EGAD00001008851 |
Rare cancer sequencing data of 75 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 49 |
EGAD00001008852 |
Rare cancer sequencing data of 50 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 34 |
EGAD00001008853 |
Rare cancer sequencing data of 44 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 30 |
EGAD00001008854 |
Rare cancer sequencing data of 40 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 26 |
EGAD00001008855 |
Rare cancer sequencing data of 97 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 61 |
EGAD00001008856 |
Rare cancer sequencing data of 48 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 33 |
EGAD00001008857 |
Rare cancer sequencing data of 58 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 40 |
EGAD00001008858 |
Rare cancer sequencing data of 49 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 35 |
EGAD00001008859 |
Rare cancer sequencing data of 243 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 164 |
EGAD00001008860 |
Rare cancer sequencing data of 47 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 41 |
EGAD00001008861 |
Rare cancer sequencing data of 92 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 62 |
EGAD00001008862 |
Rare cancer sequencing data of 145 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 104 |
EGAD00001008863 |
Rare cancer sequencing data of 119 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000 | 76 |
EGAD00001008865 |
Rare cancer sequencing data of 87 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2500,Illumina HiSeq 4000 | 87 |
EGAD00001008866 |
Rare cancer sequencing data of 48 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 48 |
EGAD00001008867 |
Rare cancer sequencing data of 12 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 12 |
EGAD00001008868 |
Rare cancer sequencing data of 94 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 91 |
EGAD00001008869 |
Rare cancer sequencing data of 46 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 46 |
EGAD00001008870 |
Rare cancer sequencing data of 62 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 59 |
EGAD00001008871 |
Rare cancer sequencing data of 119 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 117 |
EGAD00001008872 |
Rare cancer sequencing data of 54 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 52 |
EGAD00001008873 |
Rare cancer sequencing data of 30 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2500,Illumina HiSeq 4000 | 30 |
EGAD00001008874 |
Rare cancer sequencing data of 18 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 18 |
EGAD00001008875 |
Rare cancer sequencing data of 64 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2500,Illumina HiSeq 4000 | 61 |
EGAD00001008876 |
Rare cancer sequencing data of 18 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 12 |
EGAD00001008877 |
Rare cancer sequencing data of 55 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 55 |
EGAD00001008878 |
Rare cancer sequencing data of 38 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 31 |
EGAD00001008879 |
Rare cancer sequencing data of 56 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 54 |
EGAD00001008880 |
Rare cancer sequencing data of 86 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2500,Illumina HiSeq 4000 | 83 |
EGAD00001008881 |
Rare cancer sequencing data of 49 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 44 |
EGAD00001008882 |
Rare cancer sequencing data of 91 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 78 |
EGAD00001008883 |
Rare cancer sequencing data of 162 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2500,Illumina HiSeq 4000 | 149 |
EGAD00001008884 |
Rare cancer sequencing data of 83 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 71 |
EGAD00001008885 |
Rare cancer sequencing data of 96 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 89 |
EGAD00001008886 |
Rare cancer sequencing data of 29 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 28 |
EGAD00001008887 |
Rare cancer sequencing data of 66 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 58 |
EGAD00001008888 |
Rare cancer sequencing data of 48 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 41 |
EGAD00001008889 |
Rare cancer sequencing data of 22 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 17 |
EGAD00001008890 |
Rare cancer sequencing data of 76 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 72 |
EGAD00001008891 |
Rare cancer sequencing data of 164 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 159 |
EGAD00001008892 |
Rare cancer sequencing data of 42 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 42 |
EGAD00001008893 |
Rare cancer sequencing data of 112 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 100 |
EGAD00001008894 |
Rare cancer sequencing data of 34 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 28 |
EGAD00001008895 |
Rare cancer sequencing data of 49 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 43 |
EGAD00001008896 |
Rare cancer sequencing data of 137 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 138 |
EGAD00001008897 |
Rare cancer sequencing data of 246 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 250 |
EGAD00001008898 |
Rare cancer sequencing data of 34 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2500,Illumina HiSeq 4000 | 34 |
EGAD00001008899 |
Rare cancer sequencing data of 6 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 6 |
EGAD00001008900 |
Rare cancer sequencing data of 142 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 134 |
EGAD00001008901 |
Rare cancer sequencing data of 28 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 4000 | 24 |
EGAD00001008902 |
Rare cancer sequencing data of 85 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 77 |
EGAD00001008903 |
Rare cancer sequencing data of 36 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 34 |
EGAD00001008904 |
Rare cancer sequencing data of 112 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 106 |
EGAD00001008905 |
RNA-Seq, WES and WGS data of 5 rare tumor/control pairs which were submitted to other HIPO projects, not MASTER. The sequencing was always paired.
|
HiSeq X Ten,Illumina HiSeq 2000 | 11 |
EGAD00001008906 |
Part of the published data from EGAS00001004662 resulted in the publication of this study EGAS00001004813
|
HiSeq X Ten | 5 |
EGAD00001009273 |
WES/WGS sequencing data of 86 chromothriptic tumor and control runs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina HiSeq 4000 | 86 |
EGAD00001009274 |
WES/WGS sequencing data of 337 chromothriptic tumor and control runs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten,Illumina HiSeq 4000 | 319 |
EGAD00001009277 |
WES/WGS sequencing data of 44 chromothriptic tumor and control runs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 40 |
EGAD00001009278 |
WES/WGS sequencing data of 242 chromothriptic tumor and control runs, which were uploaded to umbrella studies. The sequencing was always paired
|
Illumina HiSeq 2500,Illumina HiSeq 4000 | 242 |
EGAD00001009279 |
WES/WGS sequencing data of 239 chromothriptic tumor and control runs, which were uploaded to umbrella studies. The sequencing was always paired
|
HiSeq X Ten | 218 |
Who archives the data?

Publications
Citations
Retrieving...

Retrieving...

Retrieving...

Retrieving...
